Skip to main content
SpringerLink
Log in

The pharmacology of iprindole, a new antidepressant

  • Original Investigations
  • Published:
Psychopharmacologia Aims and scope Submit manuscript

Summary

Iprindole, a tricyclic indole antidepressant shares in common with imipramine-type antidepressants the ability to potentiate the central effects of amphetamine, and potentiate the peripheral effects of direct acting catecholamines. In contrast to imipramine-type compounds iprindole does not inhibit H3NE uptake centrally or peripherally, does not block the peripheral actions of indirect acting sympathomimetic amines nor block the inhibiting effects of guanethidine on the vas deferens preparation. These findings suggest that iprindole enhances activity of adrenergic receptors through a mechanism unrelated to inhibition of reuptake of norepinephrine.

The minimal anticholinergic and antihistaminic activity of iprindole supports the contention that these effects are unnecessary for antidepressant activity.

Tests involving potentiation of amphetamine proved to be more predictive of the antidepressant activity of iprindole than tests involving reserpine antagonism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anton, A. H., and D. F. Sayre: A study of the factors affecting the aluminum oxidetrihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. exp. Ther. 138, 360–375 (1962).

    Google Scholar 

  • Askew, B. M.: A simple screening procedure for imipramine-like antidepressant agents. Life Sci. 2, 725–730 (1963).

    Google Scholar 

  • Axelrod, J., G. Hertting, and L. Potter: Effect of drugs on the uptake and release of 3H-norepinephrine in the rat heart. Nature (Lond.) 194, 297 (1962).

    Google Scholar 

  • Barsa, J. A., and N. S. Kline: Depression treated with chlorpromazine and promethazine. Amer. J. Psychiat. 113, 744–745 (1957).

    Google Scholar 

  • Baum, T., and M. I. Gluckman: In vitro interactions of the new anorexic agent Wy-5244 with cardiac and vascular tissue and with adrenergic mechanisms. J. Pharmacol. exp. Ther. 158, 510–518 (1967).

    Google Scholar 

  • Bernardi, D., S. Paglialunga, and A. Jori: Peripheral and central components in the hyperthermic effect of desipramine in reserpinized rats. J. Pharm. Pharmacol. 20, 204–209 (1968).

    Google Scholar 

  • Birmingham, A. T., and A. B. Wilson: Preganglionic and postganglionic stimulation of the guinea-pig isolated vas deferens preparation. Brit. J. Pharmacol. 21, 569–580 (1963).

    Google Scholar 

  • Boniface, K. J., O. J. Brodie, and R. P. Walton: Resistance strain gauge arches for direct measurement of heart contractile force in animals. Proc. Soc. exp. Biol. (N.Y.) 84, 263–266 (1953).

    Google Scholar 

  • Burn, J. H., and M. J. Rand: The effect of precursors of noradrenaline on the response to tyramine and sympathetic stimulation. Brit. J. Pharmacol. 15, 47–55 (1960).

    Google Scholar 

  • Carlton, P. L.: Potentiation of the behavioral effects of amphetamine by imipramine. Psychopharmacologia (Berl.) 2, 364–376 (1961).

    Google Scholar 

  • —, and P. Didamo: Augmentation of the behavioral effects of amphetaimne by atropine. J. Pharmacol. exp. Ther. 132, 91–96 (1961).

    Google Scholar 

  • Costa, E., S. Garattini, and L. Valzelli: Interactions between reserpine, chlorpromazine, and imipramine. Experientia (Basel) 16, 461–463 (1960).

    Google Scholar 

  • Cotzias, G. C., and V. P. Dole: Metabolism of amines. I. Microdetermination of monoamine oxidase in tissues. J. biol. Chem. 190, 665–672 (1951).

    Google Scholar 

  • Daneman, E. A.: Treatment of depressed patients with iprindole. Psychosomatics 8, 216–221 (1967).

    Google Scholar 

  • Domenjoz, R., and W. Theobald: Zur Pharmakologie des Tofranil R (N-(3-dimethyl aminopropyl)-iminodibenzyl hydrochlorid). Arch. int. Pharmacodyn. 120, 450–489 (1959).

    Google Scholar 

  • Dunham, N. W., and T. S. Miya: A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Amer. pharm. Ass., sci. Ed. 46, 208–209 (1957).

    Google Scholar 

  • El Deiry, N. K., A. D. Forrest, and S. K. Littman: Clinical trial of a new anti-depressant (Wy-3263). Brit. J. Psychiat. 113, 999–1004 (1967).

    Google Scholar 

  • Fielden, R., and A. L. Green: Validity of ptosis as a measure of the central depressant action of reserpine. J. Pharm. Pharmacol. 17, 185–187 (1965).

    Google Scholar 

  • Garattini, S., A. Giachetti, A. Jori, L. Pieri, and L. Valzelli: Effect of imipramine, amitriptyline and their monomethyl derivatives on reserpine activity. J. Pharm. Pharmacol. 14, 509–514 (1962).

    Google Scholar 

  • —, and A. Jori: Interactions between imipramine-like drugs and reserpine on body temperature, pp. 179–193. In S. Garattini and M. N. G. Dukes (Eds.): Antidepressant Drugs. Amsterdam: Excerpta Medica 1966.

    Google Scholar 

  • Glowinski, J., and J. Axelrod: Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature (Lond.) 204, 1318–1319 (1964).

    Google Scholar 

  • Guirgea, M., J. Dauby, S. Levis, and C. Guirgea: Un test antitetrabenazine modife pour le screening des products antidepressifs. Med. exp. (Basel) 9, 249–262 (1963).

    Google Scholar 

  • Gumulka, W., and W. Kostowski: The influence of imipramine on peripheral action of some catecholamines. Arch. int. Pharmacodyn. 169, 342–347 (1967).

    Google Scholar 

  • Halliwell, G., R. M. Quinton, and F. E. Williams: A comparison of imipramine, chlorpromazine and related drugs in various tests involving autonomic functions and antagonism of reserpine. Brit. J. Pharmacol. 23, 330–350 (1964).

    Google Scholar 

  • Hertting, G., J. Axelrod, and L. G. Whitby: Effect of drugs on the uptake and metabolism of H3-norepinephrine. J. Pharmacol. exp. Ther. 134, 146–153 (1961).

    Google Scholar 

  • Hicks, J. T.: Iprindole, a new antidepressant for use in general office practice. A double-blind, placebo-controlled study. Illinois med. J. 128, 622–226 (1965).

    Google Scholar 

  • Horovitz, Z. P., May-I Chow, and P. L. Carlton: Self-stimulation of the brain by cats: Effects of imipramine, amphetamine and chlorpromazine. Psychopharmacologia (Berl.) 3, 455–462 (1962).

    Google Scholar 

  • —, A. R. Furgiuele, J. P. High, and J. C. Burke: Comparative activities of a substituted dibenzothiazepine, of imipramine and of desipramine. Arch. int. Pharmacodyn. 151, 180–191 (1964).

    Google Scholar 

  • Johnson, J., and J. G. Maden: A new antidepressant-Pramindole (Wy-3263). A double-blind controlled trial. J. clin. Trials 4, 787–791 (1967).

    Google Scholar 

  • Kissel, J. W.: The pharmacology of MJ 1986, a phenylindene with properties of antidepressant and psychostimulant significance. In S. Garattini and M. N. G. Dukes (Eds.): Antidepressant Drugs, pp. 233–240. Amsterdam: Excerpta Medica 1966.

    Google Scholar 

  • Klerman, G. L.: Antidepressant drugs of non-MAO inhibitor type. Proceedings of a Workshop, p. 66, ed. by Efrom, D. H., and S. S. Kety. U.S. Department of Health, Education and Welfare (1966).

  • McClatchey, W. T., J. Moffat, and G. M. Irvine: A double-blind study of Wy-3263, imipramine and placebo. J. Ther. clin. Res. 5, 13–15 (1967).

    Google Scholar 

  • Olds, J., and P. Milner: Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. comp. physiol. Psychol. 47, 419–427 (1954).

    Google Scholar 

  • Pletscher, A., and K. F. Gey: Action of imipramine and amitriptyline on cerebral monoamines as compared with chlorpromazine. Med. exp. (Basel) 6, 165–168 (1962).

    Google Scholar 

  • Rosenthale, M. E., and A. Dervinis: Improved apparatus for measurement of guinea-pig lung overflow. Arch. int. Pharmacodyn. 172, 91–94 (1968).

    Google Scholar 

  • Rubin, B., M. H. Malone, M. H. Waugh, and J. C. Burke: Bioassay of Rauwolfia roots and alkaloids. J. Pharmacol. exp. Ther. 120, 125–136 (1957).

    Google Scholar 

  • Ryall, R. W.: Effects of cocaine and antidepressant drugs on the nictitating membrane of the cat. Brit. J. Pharmacol. 17, 339–357 (1961).

    Google Scholar 

  • Scheckel, C. L., and E. Boff: Behavioral effects of interacting imipramine and other drugs with D-amphetamine, cocaine, and tetrabenazine. Psychopharmacologia (Berl.) 5, 198–208 (1964).

    Google Scholar 

  • Sigg, E. B.: Pharmacological studies with Tofranil. Canad. Psychiat. Ass. J. 4, (Special Suppl.) 75–85 (1959).

    Google Scholar 

  • —, L. Soffer, and L. Gyermek: Influence of imipramine and related psychoactive agents on the effect of 5-hydroxytryptamine and catecholamines on the cat nictitating membrane. J. Pharmacol. exp. Ther. 142, 13–20 (1963).

    Google Scholar 

  • Spencer, P. S. J.: Antagonism of hypothermia in the mouse by antidepressants. In S. Garattini and M. N. G. Dukes (Eds.): Antidepressant Drugs, pp. 194 to 204. Amsterdam: Excerpta Medica 1966.

    Google Scholar 

  • Stein, L.: Effects and interactions of imipramine, chlorpromazine, reserpine and amphetamine on self-stimulation: Possible neurophysiological basis of depression. Recent Advanc. Biol. Psychiat. 4, 288–308 (1962a).

    Google Scholar 

  • —: New methods for evaluating stimulants and antidepressants. In: Psychosomatic Medicine. Symposium. Ed. by J. H. Nodine and J. H. Moyer, pp. 397–311. Philadelphia: Lea and Febiger 1962b.

    Google Scholar 

  • —: Psychopharmacological substrates of mental depression. In: Antidepressant drugs. Proceedings of the first international symposium, Milan. Ed. by S. Garattini and M. N. G. Dukes, pp. 130–140. New York: International Congress Series No. 122, Excerpta Medica Foundation 1967.

    Google Scholar 

  • —, and J. Seifter: Possible mode of antidepressive action of imipramine. Science 134, 286–287 (1961).

    Google Scholar 

  • Stone, C. A., C. C. Porter, J. M. Stavorski, C. T. Ludden, and J. A. Totaro: Antagonism of certain effects of catecholamine-depleting agents by antidepressant and related drugs. J. Pharmacol. exp. Ther. 144, 196–204 (1964).

    Google Scholar 

  • Sulser, F., M. H. Bickel, and B. B. Brodie: The action of desmethylimipramine in counteracting sedation and cholinergic effects of reserpine-like drugs. J. Pharmacol. exp. Ther. 144, 321–330 (1964).

    Google Scholar 

  • Theobald, W., O. Buch, and H. A. Kunz: Vergleichende Untersuchungen über die Beeinflussung vegetativer Funktion durch Psychopharmaka im akuten Tierversuch. Arzneimittel-Forsch. 15, 117–125 (1965).

    Google Scholar 

  • — —, A. Morpurgo, and W. Schindler: Pharmacology of new centrally active tricyclic compounds. In S. Garattini and M. N. G. Dukes (Eds.): Antidepressant Drugs, pp. 205–207. Amsterdam: Excerpta Medica 1966.

    Google Scholar 

  • Thoenen, H., A. Huerlimamn, and W. Haefely: Mode of action of imipramine and 5-(3-methylaminopropyliden)-dibenzo (a,e) cyolohepta (1,3,5) trien hydrochloride (Ro 4-6011), a new antidepressant drug, on peripheral adrenergic mechanisms. J. Pharmacol. exp. Ther. 144, 405–414 (1964).

    Google Scholar 

  • Valzelli, L., S. Consolo, and C. Morpurgo: Influence of imipramine-like drugs on the metabolism of amphetamine. In S. Garattini and M. N. G. Dukes (Eds.): Antidepressant Drugs, pp. 61–69. Amsterdam: Excerpta Medica 1966.

    Google Scholar 

  • Vernier, V. G., H. M. Hanson, and C.A. Stone: The pharmacodynamics of amitriptyline. In: Psychosomatic Medicine pp. 683–690. The first Hahnemann Symposium. Ed. by J. H. Nodine and J. H. Moyer. Philadelphia: Lea and Febiger 1962.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wyeth Laboratories, Radnor, Pennsylvania

    M. I. Gluckman & T. Baum

Authors
  1. M. I. Gluckman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Baum
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gluckman, M.I., Baum, T. The pharmacology of iprindole, a new antidepressant. Psychopharmacologia 15, 169–185 (1969). https://doi.org/10.1007/BF00411167

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00411167

Key-Words

Search

Navigation